Skip to content
healthcare.dev
Get a free key

Halaven

NDC 62856-389, eribulin mesylate, injection, from Eisai Inc..

Product NDC
62856-389
Status
Listed
Labeler
Eisai Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA201532
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62856-389 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERIBULIN MESYLATE.5 mg/mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
62856-389-01628560389011 VIAL, SINGLE-DOSE in 1 CARTON (62856-389-01) / 2 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/31ce4750-ded5-4a0b-95e9-f229fa6bc822

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=62856-389

Use it

Look up 62856-389 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62856-389 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62856-389. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.